220 related articles for article (PubMed ID: 33172406)
1. A small-molecule screen reveals novel modulators of MeCP2 and X-chromosome inactivation maintenance.
Lee HM; Kuijer MB; Ruiz Blanes N; Clark EP; Aita M; Galiano Arjona L; Kokot A; Sciaky N; Simon JM; Bhatnagar S; Philpot BD; Cerase A
J Neurodev Disord; 2020 Nov; 12(1):29. PubMed ID: 33172406
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological reactivation of inactive X-linked
Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
[TBL] [Abstract][Full Text] [Related]
3. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the parental origin of de novo MECP2 mutations and X chromosome inactivation in fifteen sporadic cases with Rett syndrome].
Zhu XW; Pan H; Li MR; Bao XH; Zhang JJ; Wu XR
Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):565-9. PubMed ID: 19951486
[TBL] [Abstract][Full Text] [Related]
5. Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.
Carrette LLG; Blum R; Ma W; Kelleher RJ; Lee JT
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8185-8190. PubMed ID: 30038001
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent expression of MeCP2 in a heterozygous mosaic mouse model.
Smrt RD; Pfeiffer RL; Zhao X
Hum Mol Genet; 2011 May; 20(9):1834-43. PubMed ID: 21330301
[TBL] [Abstract][Full Text] [Related]
7. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
8. Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP/TGF-β superfamily as a regulator of XIST expression.
Sripathy S; Leko V; Adrianse RL; Loe T; Foss EJ; Dalrymple E; Lao U; Gatbonton-Schwager T; Carter KT; Payer B; Paddison PJ; Grady WM; Lee JT; Bartolomei MS; Bedalov A
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1619-1624. PubMed ID: 28143937
[TBL] [Abstract][Full Text] [Related]
9. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
10. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
11. Early intervention with psychostimulants or antidepressants to increase methyl-CpG-binding protein 2 (MeCP2) expressions: a potential therapy for Rett syndrome.
Pan CH; Tsai S
Med Sci Monit; 2012 Jan; 18(1):HY1-3. PubMed ID: 22207122
[TBL] [Abstract][Full Text] [Related]
12. MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
Zahorakova D; Lelkova P; Gregor V; Magner M; Zeman J; Martasek P
J Hum Genet; 2016 Jul; 61(7):617-25. PubMed ID: 26984561
[TBL] [Abstract][Full Text] [Related]
13. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.
Young JI; Zoghbi HY
Am J Hum Genet; 2004 Mar; 74(3):511-20. PubMed ID: 14973779
[TBL] [Abstract][Full Text] [Related]
14. [X chromosome inactivation patterns in patients with Rett syndrome and their mothers and the parental origin of the priority inactive X chromosome].
Jiang SL; Bao XH; Song FY; Pan H; Li MR; Wu XR
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):648-52. PubMed ID: 17217653
[TBL] [Abstract][Full Text] [Related]
15. Atypical Rett syndrome in a girl with mosaic triple X and MECP2 variant.
Takahashi S; Takeguchi R; Kuroda M; Tanaka R
Mol Genet Genomic Med; 2020 Mar; 8(3):e1122. PubMed ID: 31943886
[TBL] [Abstract][Full Text] [Related]
16. Normalized Clinical Severity Scores Reveal a Correlation between X Chromosome Inactivation and Disease Severity in Rett Syndrome.
Merritt JK; Fang X; Caylor RC; Skinner SA; Friez MJ; Percy AK; Neul JL
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790223
[TBL] [Abstract][Full Text] [Related]
17. Familial cases and male cases with MECP2 mutations.
Zhang Q; Zhao Y; Bao X; Luo J; Zhang X; Li J; Wei L; Wu X
Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):451-457. PubMed ID: 28394482
[TBL] [Abstract][Full Text] [Related]
18. X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype.
Xinhua Bao ; Shengling Jiang ; Fuying Song ; Hong Pan ; Meirong Li ; Wu XR
J Child Neurol; 2008 Jan; 23(1):22-5. PubMed ID: 18184939
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic determinants of reactivation of Mecp2 and the inactive X chromosome in neural stem cells.
Mira-Bontenbal H; Tan B; Gontan C; Goossens S; Boers RG; Boers JB; Dupont C; van Royen ME; IJcken WFJ; French P; Bedalov A; Gribnau J
Stem Cell Reports; 2022 Mar; 17(3):693-706. PubMed ID: 35148843
[TBL] [Abstract][Full Text] [Related]
20. Multiplex epigenome editing of
Qian J; Guan X; Xie B; Xu C; Niu J; Tang X; Li CH; Colecraft HM; Jaenisch R; Liu XS
Sci Transl Med; 2023 Jan; 15(679):eadd4666. PubMed ID: 36652535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
